Cargando…
Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea
Nocturnal intermittent hypoxia (IH) featuring obstructive sleep apnea (OSA) dysregulates hepatic lipid metabolism and might contribute to the development of non-alcoholic fatty liver disease (NAFLD) observed in OSA patients. However, further research is required to better understanding the molecular...
Autores principales: | Rey, Esther, del Pozo-Maroto, Elvira, Marañón, Patricia, Beeler, Brittany, García-García, Yaiza, Landete, Pedro, Isaza, Stephania C., Farré, Ramón, García-Monzón, Carmelo, Almendros, Isaac, González-Rodríguez, Águeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431763/ https://www.ncbi.nlm.nih.gov/pubmed/32850919 http://dx.doi.org/10.3389/fmed.2020.00450 |
Ejemplares similares
-
Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36
por: Rey, Esther, et al.
Publicado: (2020) -
Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020) -
Sleep apnea-COPD overlap syndrome is associated with larger left carotid atherosclerotic plaques
por: Landete, Pedro, et al.
Publicado: (2023) -
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022) -
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis
por: Marañón, Patricia, et al.
Publicado: (2023)